The degree of responsiveness of lymphoid cells to activation by mitogens and antigens is commonly assessed in vitro by measuring radioactive DNA precursor incorporation. Several lines of eyidence indicate that artifacts affect the results and that these measurements may not be an accurate reflection of cell activation. Cultures of blastogenically activated lymphocytes contain soluble, noncytotoxic factors that inhibit the incorporation of radioactive nucleosides into DNA by dividing cells without affecting their rate of DNA synthesis. Inhibitors were found in the serum component of the medium and in the bacterial homogenates used to activate the cells, and they were produced by the activated cells. Inhibitor activity in serum has properties expected of a nucleoside such as thymidine, including a molecular weight of less than 103. The inhibitor activity present in some bacterial homogenates and that produced by activated cells enzymically degrade labeled DNA precursors, thereby preventing their availability for incorporation. Other bacterial preparations contain DNA precursors, which compete with labeled nucleosides for incorporation, and additional low-molecular-weight inhibitor is produced when the preparations are incubated. Preparations of various bacteria differ greatly with regard to the potency of their inhibitor activity. In some cases incorporation of label in activated cultures is reduced to background levels. Inhibition by these substances leads to erroneous conclusions regarding the proliferative activity of cultured lymphocytes, since the amount of label incorporated does not accurately indicate the true rate of DNA synthesis of the cells.
The degree of responsiveness of lymphoid cells to activation by mitogens and antigens is commonly assessed in vitro by measuring radioactive DNA precursor incorporation. Several lines of eyidence indicate that artifacts affect the results and that these measurements may not be an accurate reflection of cell activation. Cultures of blastogenically activated lymphocytes contain soluble, noncytotoxic factors that inhibit the incorporation of radioactive nucleosides into DNA by dividing cells without affecting their rate of DNA synthesis. Inhibitors were found in the serum component of the medium and in the bacterial homogenates used to activate the cells, and they were produced by the activated cells. Inhibitor activity in serum has properties expected of a nucleoside such as thymidine, including a molecular weight of less than 103. The inhibitor activity present in some bacterial homogenates and that produced by activated cells enzymically degrade labeled DNA precursors, thereby preventing their availability for incorporation. Other bacterial preparations contain DNA precursors, which compete with labeled nucleosides for incorporation, and additional low-molecular-weight inhibitor is produced when the preparations are incubated. Preparations of various bacteria differ greatly with regard to the potency of their inhibitor activity. In some cases incorporation of label in activated cultures is reduced to background levels. Inhibition by these substances leads to erroneous conclusions regarding the proliferative activity of cultured lymphocytes, since the amount of label incorporated does not accurately indicate the true rate of DNA synthesis of the cells.
Various methods of measuring the proliferative response of lymphocytes have been used in basic immunological research and in clinical studies designed to elucidate the role of the immune system in human diseases. Measuring the incorporation of radioactive DNA precursors by peripheral blood mononuclear cells (PBM) exposed in vitro to antigens or to polyclonal activators is the method most commonly used to quantitate the response. Investigators using these techniques have looked for correlations between pathological status and blastogenic responsiveness of PBM from patients with rheumatoid arthritis (24) , Hodgkin's disease (8, 9, 41) , and periodontitis (10, 11, 13, 17, 18, 20, 29, 30, 33, 34, 39) . We have been concerned mainly with the studies of blastogenic responsiveness of PBM from patients with periodontitis to homogenates and fractions obtained from various bacteria considered to be associated with this family of diseases. Although positive correlations between lymphoid cell responsiveness in vitro and pathological status of these patients have been reported (10, 13, 14, 18, 29, 39) , interpretation of the data has been hampered by variability in the results and a lack of reproducibility. In the most recent reports positive correlations have not been found (27; S. L. Donaldson, R. R. Ranney, J. A. Burmeister, and J. G. Tew, J. Periodontol., in press; S. K. Osterberg, R. C. Page, T. J. Sims, and G. Wilde, J. Clin. Periodontol., in press).
We have done experiments designed to determine whether factors other than the pathological status of the host can cause systematic errors in the results of blastogenesis assays used in past studies. For example, we have shown previously that PBM from normal subjects that do not respond to activation by pathogenic bacterial substances can be made to respond by altering the culture conditions (38) . In the present work we have assessed the effect of factors found in activated PBM cultures that have the capacity to alter the uptake of radioactive DNA precursors by activated PBM without affecting blastogenesis per se. For example, the bacterial prepara- (Tables 1 and 2 ). The data are expressed as percent enhancement rather than percent inhibition (see Fig. 2 ) to show the magnitude of the error that results when it is assumed that incorporation in unwashed control cultures accurately reflects DNA synthesis. The degree of enhancement of label incorporation was much greater in activated than unactivated cultures and varied from two-to fivefold, depending upon the cell activator used. In some cases, the difference between the amount of label incorporated by activated and unactivated cells was not significant when labeling was done in the original supematant, but was highly significant (P < 0.01) in identical cultures that had been washed and labeled in fresh serum-free medium (Table  2) .
Soluble inhibitor could derive from the bacterial homogenates, components of the medium such as serum or plasma, or from the cells, If inhibitors were present in the bacterial homogenates, the degree of inhibition would depend on the activator dose. As shown in Table 3 , in a typical experiment, the magnitude of labeling enhancement in both A. viscosus and B. melaninogenicus subsp. asaccharolyticus-activated cultures increased proportionately as the activator dose was raised from 12 to 100 ,ug/ml. At least two bacterial constituents were considered to be potentially capable of inhibiting the rate of incorporation of exogenous thymidine or thymidine analog without affecting cell viability or DNA synthesis directly. First, unlabeled free nucleoside could be present in the homogenates or it could be released from bacterial DNA during incubation via DNase activity. Second, enzymes in the homogenates could degrade labeled DNA precursors to products that cannot be incorporated into DNA.
To assess the first possibility, the following experiment was done. B. melaninogenicus subsp. asaccharolyticus, A. viscosus, Capnocytophaga sp., and F. nucleatum each were suspended in serum-free medium. Part of each suspension was stored frozen, and the remainder was filtered to dryness through a 103-daltoncutoff membrane. The ultrafiltrate of each homogenate was then frozen and stored, and the retentate was suspended in serum-free medium to the original volume, incubated at 37°C for 72 h, and filtered. The untreated suspensions and the ultrafiltrates of both fresh suspensions and incubated high-molecular-weight fractions were thawed, and samples of each were transferred to wells containing washed lymphoblasts. The cultures were incubated with [125I]UdR (plus FUdR), and label incorporation was measured. Incorporation was inhibited by each whole homogenate to the same extent demonstrated in earlier data (Table 4 ). In the case of Capnocytophaga sp., A. viscosus, and F. nucleatum, all of the inhibitory activity was accounted for in the ultrafiltrate, demonstrating that inhibition was mainly due to small molecules. In additional experiments, no activity was found in second ultrafiltrates of the retentates of any of the fresh homogenates (data not shown). In the case of the B. melaninogenicus subsp. asaccharolyticus, all of the inhibitor activity was consistently retained in the unfilterable fraction, suggesting the presence of high-molecular-weight inhibitors. Furthermore, although a 72-h incubation of the high-molecular-weight fraction of B. melaninogenicus subsp. asaccharolyticus failed to liberate low-molecular-weight inhibitors, filterable inhibitor activity was regenerated from unfilterable material in the other homogenates during (Table 6 ). Experiments were then done to determine whether the observed inhibition was a result of the presence of thymidine, a known constituent of serum and plasma (12) . The ultrafiltrate offetal calf serum inhibited label incorporation in a dose-dependent manner in each case, and the magnitude of the inhibition at a concentration of 10% (vol/vol) was comparable to that resulting from an equivalent dose of whole serum (Table 6) , as indicated by the data shown in Fig. 3 . Experiments were also done to assess the nucleosidase activity of human serum and plasma, since these may be contaminated with derivatives of platelets which are known to contain thymidine phosphorylase (32) . Table 7 shows that serum exhibited no label-degrading activity. However, when label was incubated in medium containing 10% plasma, a low but measurable level of degradation was observed.
Next, an experiment was done to determine whether nucleosidase activity could be detected in the supematants of activated and unactivated cultures after 72 h of incubation. As shown in Table 8 , all of the supernatants degraded label, including those from unactivated cultures and a As determined by thin-layer chromatography. Enzyme activity was terminated at the indicated times by adding 10o trichloroacetic acid.
[125I]UdR incubated in serum-free medium. d Abbreviations as in Table 6 .
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SIMS AND PAGE INFECT. IMMUN. Replicate unactivated (A), PHA-activated (B), and B. melaninogenicus subsp. asaccharolyticus-activated PBM cultures (C) were established and incubated for compete with labeled nucleosides for incorporation into DNA and also enzymes that degrade the labeled substrate and make it unavailable for incorporation. The net effect of these inhibitors on label incorporation varies from one microorganism or fraction to another and also depends on the degree to which the cultures are activated and on the length of incubation.
Low-molecular-weight inhibitors are present in autologous human plasma and serum, pooled human AB serum, and calf serum, and they are found in fresh homogenates of some bacteria, such as F. nucleatum and A. viscosus, but not in others, such as B. melaninogenicus subsp. asaccharolyticus. Furthermore, preparations of F. nucleatum and A. viscosus from which the inhibitors have been removed by filtration regenerate inhibitor activity during incubation, presumably through enzymatic degradation of bacterial DNA or some other slow solubilization process.
The evidence indicates that these low-molecular-weight inhibitors have significant effects on label incorporation by activated and unactivated cultures, and that the magnitude of inhibition may vary greatly, depending on the experimental design. For Variation in the nucleosidase activity among the various bacteria tested clearly causes erroneous conclusions concerning their relative capacities to induce blastogenesis in PBM. The amount of degradative activity varied greatly from one bacterium to another. For instance, a great deal of activity was present in homogenates of B. melaninogenicus subsp. asaccharolyticus, whereas in Capnocytophaga sp. homogenate activity was moderate and in A. viscosus homogenates none was detectable. Plasma, but not serum, also contained a low level of activity, and activated cells degraded a portion of labeled substrate and concurrently incorporated a portion into DNA. It should also be noted that the endogenous capacity to degrade the label apparently increases with increasing magnitude of blastogenesis and therefore tends to suppress the magnitude of differences between highly and only slightly activated cultures.
Our observations show that under commonly used conditions cultures activated with a homogenate of B. melaninogenicus subsp. asaccharolyticus degrade almost all of the label in only 60 min. Pulse-labeling periods of 4 to 24 h were used in previously published experiments. Under such conditions, cultures containing substrate-degrading activity would incorporate only small amounts of label even though the actual level of blastogenesis may be extremely high, whereas cultures containing small amounts of label-degrading activity, although activated to only low levels of blastogenesis, may incorporate large quantities of label. This problem cannot be resolved completely by washing procedures that remove the bacterial substances and serum or plasma, because the cells themselves give rise to substrate-degrading activity which varies according to the type of activator used.
The exact effects of low-molecular-weight inhibitors and substrate-degrading enzymes on the results observed by previous investigators are difficult to assess. The manner in which the bacterial activators were prepared and the exact nature of the fractions used to activate the PBM cultures would be expected to affect the degree of inhibition, and these have varied greatly. For example, some investigators have used homogenized plaque or sediment harvested from homogenates of pure cultures of bacteria; others have used soluble extracts, extracts from previously boiled homogenized plaque, or whole saliva. Dialysis would be expected to eliminate the low-molecular-weight inhibitors present in fresh homogenates, but not those generated during the period of incubation. Boiling and sonication may partly or completely denature proteins and inactivate enzyme activity.
In spite of these complications, our observations shed new light on many of the previously INFECT. IMMUN. reported observations in periodontal disease studies. In almost all of the reports, the highest stimulation indices have been reported for cultures activated with homogenates or fractions from A. viscosus and F. nucleatum, neither of which contains nucleoside-degrading activity. In contrast, in most cases, preparations of B. melaninogenicus subsp. asaccharolyticus, a gramnegative rod which is implicated as a periodontal pathogen, contain potent substrate-degrading activity and coincidentally have been found to be poor activators of PBM from periodontitis patients.
The present work extends the work of Nykanen (24) 
